Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,764.40
(
-0.13%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
104.95
(
0.49%
)
Bitcoin
70,530.00
(
0.90%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Preciouslife1 post# 67237

Thursday, 01/29/2009 7:21:53 PM

Thursday, January 29, 2009 7:21:53 PM

Post# of 257262
Factoid: There are nine CD20 mAbs in clinical development seeking to supersede Rituxan in whole or in part.

Source: Research and Markets
http://finance.yahoo.com/news/Research-and-Markets-CD20-bw-14194062.html


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today